Drug Type siRNA |
Synonyms- |
Target |
Action inhibitors, modulators |
Mechanism Bcl-xl inhibitors(Apoptosis regulator Bcl-X inhibitors), Mcl-1 modulators(Induced myeloid leukemia cell differentiation protein Mcl-1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glioblastoma | Preclinical | United States | 21 Apr 2026 |





